Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 7, 2008, Pages 594-601

  Kals, Jaak ^a   Kampus, Priit ^a   Kals, Mart ^a   Pulges, Andres ^a   Teesalu, Rein ^a   Zilmer, Kersti ^a   Kullisaar, Tiiu ^a   Salum, Tiit ^a   Eha, Jaan ^a   Zilmer, Mihkel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Arterial stiffness; Atherosclerosis; Endothelium; Inflammation; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; PENTOXIFYLLINE; PROSTAGLANDIN;

ADULT; ARTERIAL STIFFNESS; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BLOOD SAMPLING; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; HUMAN; HYPOTHESIS; MALE; NON INVASIVE PROCEDURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE WAVE; URINALYSIS;

ATHEROSCLEROSIS; ENDOTHELIUM; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASES; VASCULAR RESISTANCE;

EID: 55249103698     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510801930626     Document Type: Article

References (30)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
3. Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, et al. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 2004;64:172-8.
4. Kampus P, Muda P, Kals J, Ristimae T, Fischer K, Teesalu R, et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 2006;112:46-51.
5. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
6. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003;34:1203-6.
7. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation 2006;113:657-63.
8. Gokce N, Keaney JF, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function. A prospective study. Circulation 2002;105:1567-72.
9. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-78.
10. Holmlund A, Hulthe J, Millgard J, Sarabi M, Kahan T, Lind L. Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals. Atherosclerosis 2002;165:271-6.
11. Pradhan AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 2002;106:820-5.
12. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, et al. PRIME Study Group. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 2003;170:169-76.
13. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. Part II: Animal and human studies. Circulation 2003;108:2034-40.
14. Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005;25:279-86.
15. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000;102:840-5.
16. Mueller T, Dieplinger B, Gegenhuber A, Haidinger D, Schmid N, Roth N, et al. Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease. J Vasc Surg 2004;40:768-73.
17. Toikka JO, Niemi P, Ahotupa M, Niinikoski H, Viikari JS, Ronnemaa T, et al. Large-artery elastic properties in young men: relationships to serum lipoproteins and oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol 1999;19:436-41.
18. Arcaro G, Fava C, Dagradi R, Faccini G, Gaino S, Degan M, et al. Acute hyperhomocysteinemia induces a reduction in arterial distensibility and compliance. J Hypertens 2004;22:775-81.
19. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, et al. Pulse-wave analysis. Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002;22:147-52.
20. Schmitt M, Avolio A, Qasem A, McEniery CM, Butlin M, Wilkinson IB, et al. Basal NO locally modulates human iliac artery function in vivo. Hypertension 2005;46:227-31.
21. Kals J, Kampus P, Kals M, Pulges A, Teesalu R, Zilmer M. Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease. Atherosclerosis 2006;185:368-74.
22. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003;107:499-511.
23. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002;106:184-90.
24. Verma S, Wang CH, Lonn E, Charbonneau F, Buithieu J, Title LM. Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals. Eur Heart J 2004;25:1754-60.
25. Silverman MD, Zamora DO, Pan Y, Texeira PV, Planck SR, Rosenbaum JT. Cell adhesion molecule expression in cultured human iris endothelial cells. Invest Ophthalmol Vis Sci 2001;42:2861-6.
26. Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, et al. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens 2006;19:902-8.
27. Kals J, Kampus P, Kals M, Teesalu R, Zilmer K, Pulges A, et al. Arterial elasticity is associated with endothelial vasodilatory function and asymmetric dimethylarginine level in healthy subjects. Scand J Clin Lab Invest 2007;67:536-44.
28. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-9.
29. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol 2004;286:779-84.
30. Chan NN, Colhoun HM, Vallance P. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol 2001;38:1814-20.